Skip to content

Drug interactions

Crizotinib + Deutetrabenazine

Severity: Moderate

Crizotinib and Deutetrabenazine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, although deutetrabenazine has little effect at recommended doses. Combined use could add to the risk of torsades de pointes, especially with bradycardia or electrolyte disturbances.

What this interaction means in plain words

Crizotinib and Deutetrabenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Crizotinib belongs to Oncology; Deutetrabenazine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive QT prolongation (pharmacodynamic).

What to do

Obtain a baseline ECG and correct potassium and magnesium. Monitor ECG periodically during combined therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Crizotinib and Deutetrabenazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Crizotinib with Deutetrabenazine?

MediHelp rates the interaction as moderate. Crizotinib and Deutetrabenazine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, although deutetrabenazine has little effect at recommended doses. Combined use could add to the risk of torsades de pointes, especially with bradycardia or electrolyte disturbances.

How serious is the interaction between Crizotinib and Deutetrabenazine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct potassium and magnesium. Monitor ECG periodically during combined therapy.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in